← Leaderboards
Daphne A. Haas-Kogan
Dana-Farber Cancer Inst
$5,585,485
Attributed
$8,160,863
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.6M · FY2015–25$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,943,578 · 7
By mechanism
U54$6,334,512 · 3
R01$4,272,551 · 2
P50$2,336,515 · 2
Top collaborators
- Adam Cain Resnick5 shared
- William A Weiss5 shared
- Franziska Michor3 shared
- Dipanjan Chowdhury2 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Rosalind A Segal$29,230,271
- Franziska Michor$16,040,992
- Nathanael Schiander Gray$36,761,550
- Rameen Beroukhim$9,639,646
- Dipanjan Chowdhury$12,356,287
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsChildhoodChildCellsDaphne PlantResponseTumorDoctor Of PhilosophyAdultDoctor Of MedicineRadiationNeoplastic CellMolecularGeneticMutationMalignant NeoplasmsResearch PersonnelPediatric NeoplasmPathway InteractionsRecurrencePhosphotransferasesResistanceFundingTumor Tissue
Grant awards (22)
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science$1,606,288
U54 · FY2025 · CA · contact PI
Enhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities$870,926
R01 · FY2025 · CA
Project 2: Druggable dependencies in diffuse midline gliomas$470,606
P50 · FY2025 · CA · contact PI
Research Project 1: Diffuse Midline Glioma$331,007
U54 · FY2025 · CA · contact PI
Administrative Core$297,443
U54 · FY2025 · CA · contact PI
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science$1,531,427
U54 · FY2024 · CA · contact PI
Enhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities$767,009
R01 · FY2024 · CA
Project 2: Druggable dependencies in diffuse midline gliomas$487,885
P50 · FY2024 · CA · contact PI
Research Project 1: Diffuse Midline Glioma$263,663
U54 · FY2024 · CA · contact PI
Administrative Core$235,759
U54 · FY2024 · CA · contact PI
Radiation Oncology at the Interface of Pediatric Cancer Biology and Data Science$1,645,000
U54 · FY2023 · CA · contact PI
Research Project 1: Diffuse Midline Glioma$372,253
U54 · FY2023 · CA · contact PI
Administrative Core$51,672
U54 · FY2023 · CA · contact PI
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)$317,619
P50 · FY2022 · CA · contact PI
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)$358,935
P50 · FY2021 · CA · contact PI
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)$364,103
P50 · FY2020 · CA · contact PI
Precision Medicine For Pediatric Low-Grade Gliomas$520,926
R01 · FY2019 · NS · contact PI
Project 1--Targeted therapies for pediatric low-grade astrocytoma (Eck/Wright/Haas)$337,367
P50 · FY2019 · CA · contact PI
Precision Medicine For Pediatric Low-Grade Gliomas$520,295
R01 · FY2018 · NS · contact PI
Precision Medicine For Pediatric Low-Grade Gliomas$520,168
R01 · FY2017 · NS · contact PI
Precision Medicine For Pediatric Low-Grade Gliomas$521,946
R01 · FY2016 · NS · contact PI
Precision Medicine For Pediatric Low-Grade Gliomas$551,281
R01 · FY2015 · NS · contact PI